\u6b21\u4e16\u4ee3\u578b\u30af\u30ea\u30cb\u30ab\u30eb\u30c7\u30fc\u30bf\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306f\u3001
\n\u30c7\u30fc\u30bf\u306e\u8abf\u548c\u306b\u3088\u308b\u52b9\u7387\u5316\u3068\u30b9\u30d4\u30fc\u30c9\u30a2\u30c3\u30d7\u3092\u5b9f\u73fe<\/p>\n
<\/p>\n
2023\u5e749\u670815\u65e5
\nVeeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
Veeva Clinical Database\uff08CDB\uff09<\/a>\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u306e\u9769\u65b0\u7684\u306a\u7ba1\u7406\u65b9\u6cd5\u3092\u5b9f\u73fe\u3057\u3001\u30c7\u30fc\u30bf\u306e\u96c6\u7d04\u3001\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u3001\u5909\u63db\u306b\u8981\u3059\u308b\u6642\u9593\u309230\uff5e50\uff05\u77ed\u7e2e\u3057\u307e\u3059\u3002Veeva Systems<\/a>\u3010NYSE:VEEV\u3011\uff08\u672c\u793e\uff1a\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e\uff1a\u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79\uff1aSebastian Bather\u3001\u4ee5\u4e0bVeeva\uff09\u304c\u63d0\u4f9b\u958b\u59cb\u3092\u767a\u8868\u3057\u3066\u4ee5\u6765\u3001Veeva CDB\u306f20\u4e07\u4eba\u4ee5\u4e0a\u306e\u88ab\u9a13\u8005\u306e\u30c7\u30fc\u30bf\u3092\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u3057\u3001200\u4ef6\u4ee5\u4e0a\u306e\u81e8\u5e8a\u8a66\u9a13\u3067\u8cea\u306e\u9ad8\u3044\u30c7\u30fc\u30bf\u3092\u8fc5\u901f\u306b\u63d0\u4f9b\u3057\u3066\u304d\u307e\u3057\u305f\u3002\uff08\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002\uff09<\/p>\n <\/p>\n Fortrea\u793e\u306e\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bJerry Yarem\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva CDB\u3092\u7acb\u3061\u4e0a\u3052\u3001\u305d\u308c\u3092\u4e2d\u5fc3\u306b\u30d7\u30ed\u30bb\u30b9\u3092\u69cb\u7bc9\u3059\u308b\u3053\u3068\u3067\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u30c7\u30fc\u30bf\u5909\u63db\u306e\u305f\u3081\u306e\u57fa\u790e\u56fa\u3081\u3092\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u7d20\u6674\u3089\u3057\u3044\u9032\u5c55\u3067\u3001\u3059\u3079\u3066\u306e\u30c7\u30fc\u30bf\u30bd\u30fc\u30b9\u3092\u7d71\u5408\u3057\u3001\u30af\u30ea\u30fc\u30f3\u306a\u30c7\u30fc\u30bf\u3092\u3053\u308c\u307e\u3067\u4ee5\u4e0a\u306b\u8fc5\u901f\u306b\u63d0\u4f9b\u3067\u304d\u308b\u306e\u3067\u3001\u30b9\u30bf\u30c7\u30a3\u30c1\u30fc\u30e0\u306f\u3001\u81ea\u4fe1\u3092\u6301\u3063\u3066\u30c7\u30fc\u30bf\u4e3b\u5c0e\u578b\u306e\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3046\u3053\u3068\u304c\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u300d<\/p>\n Veeva CDB\u306f\u30d7\u30ed\u30bb\u30b9\u3092\u81ea\u52d5\u5316\u3059\u308b\u3053\u3068\u3067\u3001\u751f\u7523\u6027\u3068\u52b9\u7387\u3092\u9ad8\u3081\u308b\u65b0\u3057\u3044\u30c7\u30fc\u30bf\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u65b9\u6cd5\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002Veeva CDB\u306e\u30aa\u30fc\u30c8\u30c1\u30a7\u30c3\u30af\u3092\u4f7f\u7528\u3059\u308c\u3070\u3001\u304a\u5ba2\u69d8\u306f\u30c7\u30fc\u30bf\u53d6\u308a\u8fbc\u307f\u6642\u306b\u81ea\u52d5\u7684\u306b\u4e0d\u4e00\u81f4\u3092\u7279\u5b9a\u3057\u3001\u554f\u984c\u304c\u4fee\u6b63\u3055\u308c\u305f\u5834\u5408\u306f\u30af\u30a8\u30ea\u3092\u4f5c\u6210\u3057\u305f\u308a\u3001\u30af\u30ed\u30fc\u30ba\u3057\u305f\u308a\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u307e\u305f\u3001\u3053\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306f\u5909\u66f4\u306e\u691c\u51fa\u3082\u81ea\u52d5\u3067\u884c\u3046\u305f\u3081\u3001\u30c7\u30fc\u30bf\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u306f\u6642\u9593\u7bc0\u7d04\u3068\u30b3\u30b9\u30c8\u524a\u6e1b\u3092\u3057\u306a\u304c\u3089\u65b0\u3057\u3044\u30c7\u30fc\u30bf\u3084\u66f4\u65b0\u3055\u308c\u305f\u30c7\u30fc\u30bf\u306b\u96c6\u4e2d\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n Acelyrin\u793e\u306e\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u8cac\u4efb\u8005\u3067\u3042\u308bTonya Arthur\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva CDB\u306f\u3001\u8a66\u9a13\u30d1\u30fc\u30c8\u30ca\u30fc\u3068\u30c7\u30fc\u30bf\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u304c\u5bb9\u6613\u306b\u9023\u643a\u3067\u304d\u308b\u3088\u3046\u306b\u3001\u30c7\u30fc\u30bf\u306e\u8ee2\u9001\u3084\u8a2d\u5b9a\u3092\u30b7\u30f3\u30d7\u30eb\u306b\u3057\u3066\u3044\u307e\u3059\u3002Veeva\u306e\u30af\u30ea\u30cb\u30ab\u30eb\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068CRO\u30d1\u30fc\u30c8\u30ca\u30fc\u306e\u5c02\u9580\u77e5\u8b58\u3092\u7d44\u307f\u5408\u308f\u305b\u308b\u3053\u3068\u3067\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30d7\u30ed\u30bb\u30b9\u3092\u6539\u5584\u3057\u3001\u53ef\u8996\u5316\u3055\u308c\u305f\u60c5\u5831\u3092\u3082\u3068\u306b\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3046\u3053\u3068\u304c\u3067\u304d\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u6210\u679c\u306b\u30d7\u30e9\u30b9\u306e\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u300d<\/p>\n \u30b9\u30dd\u30f3\u30b5\u30fc\u3084\u533b\u85ac\u54c1\u958b\u767a\u696d\u52d9\u53d7\u8a17\u6a5f\u95a2\uff08CRO\uff09\u306f\u3001Veeva CDB\u3092\u5229\u7528\u3057\u3066\u3001Veeva Vault EDC<\/a>\u3084Medidata Rave™<\/sup>\u3001ePRO\u3001\u81e8\u5e8a\u691c\u67fb\u30c7\u30fc\u30bf\u306a\u3069\u3001\u3055\u307e\u3056\u307e\u306a\u30b7\u30b9\u30c6\u30e0\u30bd\u30fc\u30b9\u304b\u3089\u81e8\u5e8a\u30c7\u30fc\u30bf\u3092\u53d6\u308a\u8fbc\u307f\u3001\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u30b9\u30dd\u30f3\u30b5\u30fc\u306f\u3001\u30d7\u30ed\u30bb\u30b9\u306e\u6a19\u6e96\u5316\u3068\u6700\u9069\u5316\u3092\u884c\u3044\u3001\u30b7\u30b9\u30c6\u30e0\u5168\u4f53\u3067\u52b9\u679c\u7684\u306a\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3092\u884c\u3046\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3055\u3089\u306b\u3001Veeva CDB \u30c7\u30fc\u30bf\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u30d7\u30ed\u30b0\u30e9\u30e0<\/a>\u306f\u3001\u8c4a\u5bcc\u306a\u30ea\u30bd\u30fc\u30b9\u3092\u6301\u3064\u8a8d\u5b9a\u30d1\u30fc\u30c8\u30ca\u30fc\u304cVeeva CDB\u306e\u9867\u5ba2\u306b\u5bfe\u3057\u3066\u30c7\u30fc\u30bf\u3092\u63d0\u4f9b\u3059\u308b\u969b\u306e\u904b\u7528\u52b9\u7387\u3092\u5411\u4e0a\u3055\u305b\u307e\u3059\u3002 <\/p>\n Clinical Ink\u793e\u306e\u30c7\u30fc\u30bf\u30b5\u30fc\u30d3\u30b9\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bSon Ly\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva\u3068\u306e\u30c7\u30fc\u30bf\u9001\u53d7\u4fe1\u306b\u3088\u308a\u3001Veeva CDB\u3068Clinical Ink\u793e\u306eeCOA\u3001\u30c0\u30a4\u30ec\u30af\u30c8\u30c7\u30fc\u30bf\u53ce\u96c6\u3001\u60a3\u8005\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3001\u30c7\u30b8\u30bf\u30eb\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u306e\u5305\u62ec\u30b9\u30a4\u30fc\u30c8\u3092\u4f7f\u7528\u3059\u308b\u9867\u5ba2\u306b\u5bfe\u3057\u3001\u30c7\u30fc\u30bf\u9001\u4fe1\u3092\u5408\u7406\u5316\u3059\u308b\u7d71\u5408\u30b5\u30fc\u30d3\u30b9\u306e\u63d0\u4f9b\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002\u300d<\/p>\n Veeva CDB\u306e\u30b8\u30a7\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u3067\u3042\u308bPavel Burmenko\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u30af\u30ea\u30cb\u30ab\u30eb\u30c7\u30fc\u30bf\u30bd\u30fc\u30b9\u304c\u5897\u52a0\u3057\u7d9a\u3051\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u8907\u96d1\u6027\u304c\u5897\u3059\u4e2d\u3001\u30c7\u30fc\u30bf\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u306f\u3001\u30af\u30ea\u30fc\u30f3\u30c7\u30fc\u30bf\u3068\u6d1e\u5bdf\u3078\u306e\u9053\u7b4b\u3092\u5408\u7406\u5316\u3059\u308b\u30a2\u30b8\u30e3\u30a4\u30eb\u306a\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3092\u5fc5\u8981\u3068\u3057\u3066\u3044\u307e\u3059\u3002Veeva CDB\u306f\u300130\u793e\u4ee5\u4e0a\u306e\u30c7\u30fc\u30bf\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u304b\u3089\u8a66\u9a13\u30c7\u30fc\u30bf\u306e\u63d0\u4f9b\u3092\u53d7\u3051\u3066\u304a\u308a\u3001\u30b7\u30fc\u30e0\u30ec\u30b9\u306a\u60c5\u5831\u4ea4\u63db\u3068\u9ad8\u54c1\u8cea\u306a\u30c7\u30fc\u30bf\u3078\u306e\u8fc5\u901f\u306a\u30a2\u30af\u30bb\u30b9\u3092\u5b9f\u73fe\u3059\u308b\u30af\u30ea\u30cb\u30ab\u30eb\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3092\u63a8\u9032\u3059\u308b\u3053\u3068\u3067\u6025\u6210\u9577\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n Veeva CDB\u306f\u3001EDC\u3001\u30b3\u30fc\u30c7\u30a3\u30f3\u30b0<\/a>\u3001\u30c7\u30fc\u30bf\u30af\u30ea\u30fc\u30cb\u30f3\u30b0<\/a>\u3001\u30ec\u30dd\u30fc\u30c6\u30a3\u30f3\u30b0<\/a>\u3001\u7121\u4f5c\u70ba\u5316<\/a>\u3001\u6cbb\u9a13\u85ac\u4f9b\u7d66\u7ba1\u7406<\/a>\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u6700\u65b0\u306e\u30af\u30e9\u30a6\u30c9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u3067\u3042\u308bVeeva Vault Clinical Data Management Suite<\/a>\u306e\u4e00\u90e8\u3067\u3059\u3002<\/p>\n 2023 Veeva Japan R&D and Quality Summit<\/a>\u3067\u306f\u3001Veeva CDB\u304c\u3069\u306e\u3088\u3046\u306b\u624b\u4f5c\u696d\u3092\u6e1b\u3089\u3057\u3001\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3092\u52b9\u7387\u5316\u3059\u308b\u306e\u304b\u306b\u3064\u3044\u3066\u3054\u7d39\u4ecb\u3057\u307e\u3059\u3002\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u7686\u69d8\u306f10\u67084\u65e5\u306b\u6771\u4eac\uff08\u30de\u30f3\u30c0\u30ea\u30f3\u30aa\u30ea\u30a8\u30f3\u30bf\u30eb\u6771\u4eac\uff09\u3067\u958b\u50ac\u3055\u308c\u308b\u30a4\u30d9\u30f3\u30c8\u306b\u3054\u767b\u9332<\/a>\u3044\u305f\u3060\u3051\u307e\u3059\u3002<\/p>\n \u3010\u8ffd\u52a0\u60c5\u5831\u3011<\/strong> <\/p>\n \u3010Veeva Systems\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Veeva Forward-looking Statements\u3011<\/strong> \u8a66\u9a13\u30c7\u30fc\u30bf\u306e\u96c6\u8a08\u3068\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306e\u6642\u9593\u309230\uff5e50\uff05\u524a\u6e1b\u3002<\/p>\n","protected":false},"author":129,"featured_media":46014,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-48736","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/48736"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=48736"}],"version-history":[{"count":8,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/48736\/revisions"}],"predecessor-version":[{"id":48745,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/48736\/revisions\/48745"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media\/46014"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=48736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=48736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=48736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nVeeva CDB\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306f\u3001\u3053\u3061\u3089\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\uff1aveeva.com\/VeevaCDB<\/a>
\nVeeva CDB\u306e\u30c7\u30fc\u30bf\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306f\u3001\u3053\u3061\u3089\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\uff1aveeva.com\/CDBdataprovider<\/a>
\nLinkedIn\u4e0a\u3067Veeva\u306b\u30a2\u30af\u30bb\u30b9\u3059\u308b\u306b\u306f\uff1alinkedin.com\/company\/veeva-systems<\/a><\/p>\n
\nVeeva Systems\u793e\u306f\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f01\u696d\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u30671,000\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30d1\u30d6\u30ea\u30c3\u30af\u30fb\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3<\/a>\u4f01\u696d\u3068\u3057\u3066Veeva\u306f\u3001\u304a\u5ba2\u69d8\u3084\u5f93\u696d\u54e1\u3001\u63d0\u643a\u4f01\u696d\u3001\u682a\u4e3b\u3001\u30b5\u30fc\u30d3\u30b9\u63d0\u4f9b\u696d\u754c\u3092\u542b\u3080\u3059\u3079\u3066\u306e\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306e\u5229\u76ca\u30d0\u30e9\u30f3\u30b9\u3092\u4fdd\u3064\u3053\u3068\u306b\u30b3\u30df\u30c3\u30c8\u3057\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001www.veeva.com\/jp\/<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements regarding Veeva\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended April 30, 2023, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 37 and 38), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"